Corporate Profile
  Share Information
  Financial information
  Press releases
  2010
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001
  2000
  Presentations
  Shareholder Services
  Event Calendar
  Investor Relations Contact

Crucell's press releases are available via an RSS feed. To add this RSS feed to your reader, right click on the RSS button, click "Copy Shortcut" and add the URL to your feed reader.

RSS

If you are new to RSS, we suggest you read the Introduction to RSS article.

Press Releases


Dutch | German
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

14 Nov 2001 Galapagos Genomics and Pharmacia enter Three Year Gene Target Identification Collaboration
22 Oct 2001 Galapagos Genomics and Procter & Gamble Pharmaceuticals Announce Functional Genomics Collaboration
22 Oct 2001 Crucell Announces 3rd Quarter 2001 Results
05 Oct 2001 Professor Ada Kruisbeek To Lead Crucell's Antibody Research
28 Sep 2001 Crucell Appoints Director of Business Development for its Biotherapeutics Production Platform
20 Sep 2001 Crucell Appoints Dr Jaap Goudsmit As Senior Vice President Vaccine Research
30 Aug 2001 Galapagos Genomics and VIB Announce Functional Genomics Collaboration in Alzheimer's Disease
29 Aug 2001 Crucell Appoints VP Corporate Development & Strategy
23 Aug 2001 Crucell announces the issuance of a major patent in the field of Phage Antibodies
22 Aug 2001 Galapagos Genomics and Vertex Pharmaceuticals in Gene Function Collaboration
16 Aug 2001 Crucell will be holding a Conference Call regarding the Centocor Agreement
16 Aug 2001 Crucell enters development and commercialization agreement with Centocor for human antibodies against cancer
24 Jul 2001 Crucell announces 2nd Quarter 2001 Results
11 Jul 2001 Crucell Presents Advact(TM), a New Improved Vaccine
28 Jun 2001 Crucell and Vaxin to jointly develop new type of vaccines which make injections obsolete
26 Jun 2001 Crucell signs PER.C6 license and production agreement with Selective Genetics
13 Jun 2001 Galapagos Genomics and Bayer Announce Functional Genomics Collaboration in Asthma Research
01 Jun 2001 Crucell presents Advac , a new improved vaccine technology
23 May 2001 Crucell boosts its target discovery and antibody development engine
15 May 2001 Crucell and University Medical Center Utrecht cooperate on Antibody and Vaccine treatment for Type 2 Diabetes
08 May 2001 Crucell announces First Quarter Results
26 Apr 2001 Crucell Q1 conference call invitation
10 Apr 2001 Crucell Appoints Executive Director of Business Development for its Antibody Business
03 Apr 2001 Crucell's PER.C6 Cell-Line Used In Merck's HIV-1 Vaccines Research Program
12 Mar 2001 Crucell's Revenues in 2000 Increase 116%
31 Jan 2001 Crucell Signs Production Agreement with DirectGene
15 Jan 2001 Crucell Signs Licensing Deal With Cell Genesys for PER.C6 Packaging Cell Technology
11 Jan 2001 Crucell Appoints Executive Director of Intellectual Property